Format

Send to

Choose Destination
See comment in PubMed Commons below
Bull Cancer. 2003 May;90(5):393-8.

[Kaposi's sarcoma].

[Article in French]

Author information

  • 1Hôpital Antoine-Béclère, 157, rue de la Porte-de-Trivaux, 92141 Clamart.

Abstract

Kaposi's sarcoma (SK) is a cutaneous disease mostly affecting elderly men of Mediterranean ancestry, people from sud-Saharan Africa and HIV infected patients. It is a proliferation of spindle cells. It's neoplastic origin remains controversial. Infection with a gamma herpes virus HHV8 is necessary for the development of KS. In organ recipient patients KS is observed and seems to be related to immune deficiency. In HIV infected patients an effect of HIV as a promoter on KS is added to immune deficiency. Half of HIV-HHV8 co-infected patients may develop KS. Therapeutic management of HIV infected KS patients is primarily to treat HIV infection. This treatment contributed to a dramatic decrease of KS incidence in developed countries. When antiretroviral treatment failed, conventional chemotherapy can be used. New therapies taking in count the complex mechanisms of the KS genesis are under evaluation.

Copyright John Libbey Eurotext 2003.

PMID:
12850761
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Libbey Eurotext
    Loading ...
    Write to the Help Desk